Anti-Ro/SSA antibodies may contribute to immune-mediated LQTS by impairing hERG-K+ channel function and inhibiting IKr, ultimately leading toTdP and increasing the risk of SCD (46, 47). This evidence concerns the gene TRIM21 and familial long QT syndrome.